Keros Therapeutics (KROS)
Develops protein therapeutics for neuromuscular disease and blood-cell disorders.
$11.64
vs last close−0.09 (−0.77%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 42 days
EPS estimate
−$0.96
Revenue estimate
$14.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$1.14$3.62−$0.76−$0.18−$0.86−$1.21−$1.45Pending
Estimate−$1.36−$0.01−$1.14−$1.11−$0.49−$0.92−$1.34−$0.96
Surprise+16.2%+36,300.0%+33.3%+83.8%−75.5%−31.5%−8.2%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$3.0M$211.2M$18.2M$14.3M$385.0K$367.0K—Pending
Estimate$22.2M$56.6M$3.2M$3.7M$3.7M$1.9M$807.1K$14.8M
Surprise−86.3%+272.9%+465.9%+289.4%−89.5%−81.0%——
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$2.29 | — | — |
| Sep 2028 | −$2.29 | — | — |
| Jun 2028 | −$2.26 | — | — |
| Mar 2028 | −$2.18 | — | — |
| Dec 2027 | −$1.79 | — | — |
| Sep 2027 | −$1.75 | — | — |
| Jun 2027 | −$1.65 | — | — |
| Mar 2027 | −$1.48 | — | — |
| Dec 2026 | −$1.93 | — | — |
| Nov 2026 | −$0.96 | — | — |
| Aug 2026 | −$1.34 | −$1.45 | −8.2% |
| May 2026 | −$0.92 | −$1.21 | −31.5% |
| Mar 2026 | −$0.49 | −$0.86 | −75.5% |
| Nov 2025 | −$1.11 | −$0.18 | +83.8% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Apr 2020 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$2.29 | — | — | $677.9K | — | — | — |
| Sep 2028 | −$2.29 | — | — | $0 | — | — | — |
| Jun 2028 | −$2.26 | — | — | $0 | — | — | — |
| Mar 2028 | −$2.18 | — | — | $573.4K | — | — | — |
| Dec 2027 | −$1.79 | — | — | $433.3K | — | — | — |
| Sep 2027 | −$1.75 | — | — | $433.3K | — | — | — |
| Jun 2027 | −$1.65 | — | — | $433.3K | — | — | — |
| Mar 2027 | −$1.48 | — | — | $433.3K | — | — | — |
| Dec 2026 | −$1.93 | — | — | $478.6K | — | — | — |
| Nov 4, 2026 | −$0.96 | — | — | $14.8M | — | — | — |
| Aug 3, 2026 | −$1.34 | −$1.45 | −8.2% | $807.1K | — | — | +1.4% |
| May 14, 2026 | −$0.92 | −$1.21 | −31.5% | $1.9M | $367.0K | −81.0% | −8.3% |
| Mar 4, 2026 | −$0.49 | −$0.86 | −75.5% | $3.7M | $385.0K | −89.5% | +2.8% |
| Nov 5, 2025 | −$1.11 | −$0.18 | +83.8% | $3.7M | $14.3M | +289.4% | +0.6% |
| Aug 6, 2025 | |||||||
| May 6, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 8, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 6, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 4, 2023 | |||||||
| Mar 3, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Mar 9, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Mar 25, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 13, 2020 | |||||||
| May 22, 2020 | |||||||
| Apr 8, 2020 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 |